Oncimmune (ONC) Insider Trading & Ownership GBX 15.35 +0.20 (+1.32%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsHeadlinesInsider Trades Oncimmune (LON:ONC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage30.97%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)£9,726.21Number OfInsiders Selling(Last 12 Months)0 Get ONC Insider Trade Alerts Want to know when executives and insiders are buying or selling Oncimmune stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ONC Insider Buying and Selling by Quarter Ad Genesis Gold GroupBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now Oncimmune Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/8/2023Martin GouldstoneInsiderBuy36,023GBX 27£9,726.21 (Data available from 1/1/2013 forward) ONC Insider Trading Activity - Frequently Asked Questions Who is on Oncimmune's Insider Roster? The list of insiders at Oncimmune includes Adam Hill, and Martin Gouldstone. Learn more on insiders at ONC. What percentage of Oncimmune stock is owned by insiders? 30.97% of Oncimmune stock is owned by insiders. Learn more on ONC's insider holdings. Which Oncimmune insiders have been buying company stock? The following insiders have purchased ONC shares in the last 24 months: Adam Hill (£10,157.70), and Martin Gouldstone (£9,726.21). How much insider buying is happening at Oncimmune? Insiders have purchased a total of 84,393 ONC shares in the last 24 months for a total of £19,883.91 bought. Oncimmune Key ExecutivesMr. Martin John Gouldstone (Age 58)CEO & Director Mr. Martin HudsonFinance DirectorMr. Ron Kirschner (Age 45)COO, General Counsel & Company Secretary Prof. Tariq Sethi B.Sc.FRCP, M.A., M.D., Ph.D., Chief Scientific OfficerMs. Cléa RosenfeldHead of Investor RelationsMr. Maarten BrusseChief Commercial Officer of Asia More Insider Trading Tools from MarketBeat Related Companies TRX Insider Selling POLB Insider Selling SAR Insider Selling BVX Insider Selling ROQ Insider Selling FAB Insider Selling OBD Insider Selling DEST Insider Selling RENE Insider Selling OCTP Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (LON:ONC) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersThe #1 ETF for monthly incomeWe just found the #1 ETF for monthly income. This outlier is paying a huge 22% dividend... And you could...Investors Alley | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncimmune Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.